Rafael Mendoza Rodriguez
General Practice · Ponce, PRNPI 1780728873
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $57,650 of the $77,013 with a category attached, or 74.9%. Johnson & Johnson accounts for 61.7% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $34,298 and has fallen 91.3% since, to $2,973 in 2025. Among general practice clinicians in PR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 191 payments — averaging $403.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$47K
- Janssen Scientific Affairs, LLC$10K
- Merck$8K
- Viiv Healthcare Company$5K
- Gilead$4K
- Janssen Products, LP$3K
- plus $344 from 5 others
Across 116 payments — averaging $4435.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$351K
- AbbVie$163K
What the payments were for
- Consulting fees$8,54011%
- Speaking & faculty fees$57,65075%
- Travel & lodging$6,8999%
- Food & beverage$3,6315%
- Education$2930%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 70 | $47,489 |
| Janssen Scientific Affairs, LLC | 13 | $10,024 |
| Merck | 42 | $7,690 |
| Viiv Healthcare Company | 26 | $4,619 |
| Gilead | 23 | $3,919 |
| Janssen Products, LP | 5 | $2,928 |
| Theratechnologies Inc. | 7 | $134 |
| AbbVie | 2 | $134 |
| E.r. Squibb & Sons, L.L.C. | 1 | $39 |
| Novartis | 1 | $20 |
| Medline Industries LP | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$77,013 in reported general payments places this provider in the 95th percentile of 3,586 general practice providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 135 | $551,103 |
| TriumeqAbacavir/Dolutegravir/Lamivudi | 43 | $181,592 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 37 | $174,835 |
| DovatoDolutegravir Sodium/Lamivudine | 36 | $130,913 |
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 29 | $105,274 |
| Egrifta SvTesamorelin Acetate | 11 | $94,840 |
| DescovyEmtricitabine/Tenofov Alafenam | 40 | $87,270 |
| JulucaDolutegravir/Rilpivirine | 20 | $77,662 |
| Isentress HdRaltegravir Potassium | 28 | $55,283 |
| TivicayDolutegravir Sodium | 15 | $33,581 |
| EliquisApixaban | 22 | $11,907 |
| SynthroidLevothyroxine Sodium | 26 | $1,707 |
| HumalogInsulin Lispro | 15 | $1,427 |
| Divalproex Sodium | 16 | $1,220 |
| Sulindac | 27 | $1,168 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Descovy | $3,919 | $638,374175 claims |
| Viiv Healthcare CompanyTriumeq, Dovato, Juluca, Tivicay | $4,619 | $423,749114 claims |
| Janssen Products, LPSymtuza | $2,928 | $174,83537 claims |
| Theratechnologies Inc.Egrifta Sv | $134 | $94,84011 claims |
| MerckIsentress Hd | $7,690 | $55,28328 claims |
| AbbVieSynthroid | $134 | $1,70726 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,586 general practice providers in Puerto Rico.
Other general practice in Ponce
- Soria Diaz BaezPonce$192K
- Helen RuizPonce$5K
- Wilfredo CuevasSan Lorenzo$530K
- Julio BacoMayaguez$268K
- Carlos RomanCanovanas$140K
- William E TorresSan Juan$86K
- Frank Perez NogueiraSan German$70K
- Vivian Tamayo AgraitSan Juan$64K
- William Soto AvilesToa Baja$63K
- Jessica RosarioSanturce$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.